Close

UPDATE: Edwards Lifesciences (EW) Posts Q3 EPS of 58c; Sees FY12 Revs at Low-End of Range, Guides 4

October 19, 2012 4:02 PM EDT
(Updated - October 19, 2012 4:05 PM EDT)

Edwards Lifesciences Corp. (NYSE: EW) reported Q3 EPS of $0.58, versus the analyst estimate of $0.56. Revenue for the quarter came in at $447.9 million versus the consensus estimate of $476.56 million.

Edwards Lifesciences Corp. sees Q4 2012 revenue of $490-520 million, versus the consensus of $504.8 million.

Sees FY12 sales at bottom-end of $1.90 billion to $1.97 billion range.

For earnings history and earnings-related data on Edwards Lifesciences Corp. (EW) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance, Hot Guidance

Related Entities

Earnings